I am a Partner at Averin, based in the San Francisco Bay Area, where I invest at the intersection of life sciences, healthcare, and technology. I partner with teams advancing therapeutics, care delivery, and the software infrastructure shaping the future of healthcare and life sciences.

I believe transformative technologies, when paired with exceptional teams, can meaningfully improve human health at scale.

Previously, I led the life sciences and healthcare technology strategy at Novo Holdings and was a Partner at Andreessen Horowitz (a16z), where I supported investments across therapeutics, AI drug discovery, life sciences technology, and digital health.

I also serve as a Scout Partner at Sequoia Capital, where I invest in early-stage companies applying AI to life sciences and healthcare.

I earned my MD from Yale, MBA from Harvard Business School, and AB in Molecular and Cellular Biology from Harvard. My work has been recognized on the Forbes 30 Under 30 List for Venture Capital. 

 

I’m a third-generation San Franciscan and avid squash player.

​